Urovalve at the 2010 OneMedForum
Harvey Homan, President and CEO of Urovalve, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
Harvey Homan, President and CEO of Urovalve, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
Inovio is developing a universal flu vaccine engineered to prevent several strains of influenza at once.
The company’s key product is a portable hydration monitor that can gauge an individual’s level of hydration from a drop of saliva in approximately one minute.
Michael Weickert, President and CEO of SEA Medical Systems, Inc., discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San Francisco.
How do cancer cells evade the immune system, growing undetected until they’re discovered as a tumor?
Anna Gluskin, President and CEO of Generex Biotechnology, discusses her company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
Oramed Pharmaceuticals in Jerusalem is developing a product that could potentially revolutionize the way diabetes is treated.
George Carpenter, CEO of CNS Response, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
An interview with Rick Hughes, President of HealthLink Europe, at the 2010 OneMedForum conference.
The Aliso Viejo, Calif.-based company achieved several major milestones in 2009.
Copyright © 2024 | WordPress Theme by MH Themes